FDA Investigator Jose Melendez
Jose Melendez has inspections in 1 countries as of 31 May 2023. Jose Melendez has collaborated with a combined 1098 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
31 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Agnes M Santori,
Alan A Rivera,
Angelica M Hernandez,
Ariel Cruz Figueroa,
Arlene M Badillo,
Brenda Rivera,
Carlos A Medina,
Cheryl A Clausen,
Dayna I Martinez,
Erika E Englund, PhD,
German Rivera,
Hector J Colon Torres,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
Joan Cantellops Figueroa,
Joan M Cantellops Figueroa,
Jorge L Gonzalez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose Fpedrode Jesus,
José Meléndez,
Jose R Lopez,
Jose Rflores Veguilla,
Jose Velez,
Karl D Hezel,
Laiza V Garcia,
Laurimer Kuilan,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Lopez,
Loreily Figueroa,
Loreily Figueroa Agrinsoni,
LT Luis O Rodriguez,
Margarita Santiago,
Marian E Ramirez,
Miguel A Martinez,
Milva E Melendez,
Myriam M Sosa,
Nancy Rosado,
Noreen Muniz,
Patrick C Klotzbuecher,
Paul L Bellamy,
Rafael E Arroyo,
Rafael E Cruz,
Rafael Nevarez,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Santos E Camara,
Sonia M Monges,
Tiara Nbrown Crosen,
Vilmary Negron Rodriguez,
Yeissa Chabrier Rosello
Jose Melendez's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2011 | EIR | Pfizer Pharmaceuticals LLC - EIR, 2011-09-01 |
April, 2002 | FDA 483 | TAPI Puerto Rico, Inc. - Form 483, 2002-04-11 |
June, 2012 | FDA 483 | Auro PR Inc. - Form 483, 2012-06-07 |
April, 2002 | EIR | TAPI Puerto Rico, Inc. - EIR, 2002-04-11 |
June, 2012 | EIR | Auro PR Inc. - EIR, 2012-06-07 |
November, 2011 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2011-11-03 |
September, 2011 | FDA 483 | Pfizer Pharmaceuticals LLC - Form 483, 2011-11-01 |
February, 2024 | FDA 483 | Lilly del Caribe, Inc. - Form 483, 2024-02-16 |
March, 2024 | FDA 483 | Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483, 2024-03-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more